Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a single center pilot study testing the use of novel coil arrays with MR liver imaging. In part A of the study, up to 30 healthy volunteers will be scanned, with iterative adjustment of coil array geometry and design to optimize imaging characterstics. In Part B of the study, 40 patients with advanced solid tumors and at least one liver metastasis measuring > 1.5 cm in diameter on standard anatomic scans will undergo MR liver imaging with the newly designed coil array, with the use of gadolinium contrast. Patients with liver tumors will have the option of undergoing a second MR liver scan during the course of subsequent systemic therapy.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| MRI | Day 1 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| MRI | Procedure |
|
| Measure | Description | Time Frame |
|---|---|---|
| Spatial Resolution | Adjust the coil array to optimize spatial resolution in healthy volunteers | Day 1 |
| Scan coverage | Adjust the coil array to optimize scan coverage of the liver in healthy volunteers | Day 1 |
| Mean contrast-to-noise ratio | Detectable using the coil array | Day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Minimum size of detectable metastatic lesion | Detected by MRI scan | Day 1 |
| Degree signal | Detected by gandolinium contrast in MRI scan within liver metastases |
Not provided
Inclusion Criteria (Part B only - Patients with advanced solid tumor):
Exclusion Criteria (Part B only):
Exclusion Criteria (Part A [Healthy Volunteers] and Part B):
Not provided
Not provided
Not provided
Patients with Advanced Solid Tumor Malignancies
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Rahul Aggarwal, MD | University of California, San Francisco | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94115 | United States |
Not provided
Not provided
Not provided
Not provided
| Day 1 |
| Time-to-peak signal | Detected by gandolinium contrast in MRI scan within liver metastases | Day 1 |